HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Exposure to abacavir and biomarkers of cardiovascular disease in HIV-1-infected patients on suppressive antiretroviral therapy: a longitudinal study.

AuthorsAndrea De Luca, Katleen de Gaetano Donati, Alessandro Cozzi-Lepri, Manuela Colafigli, Amalia De Curtis, Maria Rosaria Capobianchi, Andrea Antinori, Andrea Giacometti, Giacomo Magnani, Vincenzo Vullo, Roberto Cauda, Licia Iacoviello, Antonella d'Arminio Monforte, ICoNA Foundation Study Group
JournalJournal of acquired immune deficiency syndromes (1999) (J Acquir Immune Defic Syndr) Vol. 60 Issue 3 Pg. e98-101 (Jul 01 2012) ISSN: 1944-7884 [Electronic] United States
PMID22728753 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-HIV Agents
  • Biomarkers
  • Dideoxynucleosides
  • Fibrin Fibrinogen Degradation Products
  • IL6 protein, human
  • Interleukin-6
  • Vascular Cell Adhesion Molecule-1
  • fibrin fragment D
  • C-Reactive Protein
  • abacavir
Topics
  • Anti-HIV Agents (administration & dosage, adverse effects)
  • Biomarkers (blood)
  • C-Reactive Protein (metabolism)
  • Cardiovascular Diseases (blood, etiology)
  • Dideoxynucleosides (administration & dosage, adverse effects)
  • Fibrin Fibrinogen Degradation Products (metabolism)
  • HIV Infections (complications, drug therapy)
  • HIV-1
  • Humans
  • Interleukin-6 (blood)
  • Longitudinal Studies
  • Risk Factors
  • Time Factors
  • Vascular Cell Adhesion Molecule-1 (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: